Lloyds bank has reportedly reached a settlement deal with the US Department of Justice over allegations the lender manipulated the LIBOR benchmark rate.
According to reports, Lloyds Banking Group has admitted to wrongdoing and agreed to pay $86 million in fees for the LIBOR manipulation. The settlement was first announced by the DOJ’s Antitrust Division, and reports say the details regarding the settlement were expected to be filed in court on Monday.
The bank has also agreed to continue to cooperate with the DOJ’s investigation into the matter.
In a statement, Deputy Assistant Attorney General Brent Snyder of the DOJ’s Antitrust Division said “Lloyds manipulated benchmark rates, allowing its traders to increase their profits unfairly and fraudulently.”
The settlement is only the latest development in the long-lasting, global scandal. Reports say about $283 million in penalties have been imposed on Lloyds for similar allegations by authorities including the Commodity Futures Trading Commission and the UK’s Financial Conduct Authority. Including the DOJ’s latest fine, Lloyds has been penalized nearly $370 million for the alleged LIBOR manipulation.
Full content: eNews Park Forest
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas